(Q83353652)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22287152%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

Design, synthesis and biological evaluation of noncovalent inhibitors of human CD38 NADase (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22287152%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22287152%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

Yi Zhou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22287152%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Kai Yiu Ting

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22287152%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Connie Mo Ching Lam

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22287152%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Anna Ka Yee Kwong

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22287152%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Hongwei Jin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22287152%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Zhenming Liu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22287152%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Liangren Zhang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22287152%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Hon Cheung Lee

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22287152%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Lihe Zhang

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22287152%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

publication date

3 January 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22287152%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22287152%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22287152%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22287152%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

223-228

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22287152%20AND%20SRC:MED&resulttype=core&format=json

Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage

21 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100487

7 January 2021

Enzymatic functions and structures of CD38 and homologs.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100487

7 January 2021

Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100487

7 January 2021

ADP-ribosyl cyclase and CD38 catalyze the synthesis of a calcium-mobilizing metabolite from NADP

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100487

7 January 2021

Synthesis and degradation of cyclic ADP-ribose by NAD glycohydrolases

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100487

7 January 2021

Production and hydrolysis of cyclic ADP-ribose at the outer surface of human erythrocytes

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100487

7 January 2021

Physiological functions of cyclic ADP-ribose and NAADP as calcium messengers

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100487

7 January 2021

Nicotinic acid adenine dinucleotide phosphate (NAADP)-mediated calcium signaling

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100487

7 January 2021

https://api.crossref.org/works/10.1002%2FCMDC.201100487

1 reference

7 January 2021

Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100487

7 January 2021

Autoantibodies against CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) that impair glucose-induced insulin secretion in noninsulin- dependent diabetes patients

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100487

7 January 2021

Role of CD38 in HIV-1 infection: an epiphenomenon of T-cell activation or an active player in virus/host interactions?

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100487

7 January 2021

Human CD38 interferes with HIV-1 fusion through a sequence homologous to the V3 loop of the viral envelope glycoprotein gp120.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100487

7 January 2021

CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100487

7 January 2021

In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100487

7 January 2021

The CD38 ectoenzyme family: advances in basic science and clinical practice

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100487

7 January 2021

Human CD38 is an authentic NAD(P)+ glycohydrolase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100487

7 January 2021

Mechanism-based inhibitors of CD38: a mammalian cyclic ADP-ribose synthetase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100487

7 January 2021

Carbanicotinamide adenine dinucleotide: synthesis and enzymological properties of a carbocyclic analogue of oxidized nicotinamide adenine dinucleotide

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100487

7 January 2021

Inhibition of the intrinsic NAD+ glycohydrolase activity of CD38 by carbocyclic NAD analogues

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100487

7 January 2021

Flavonoids as inhibitors of human CD38

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100487

7 January 2021

Crystal structure of human CD38 extracellular domain

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100487

7 January 2021

Structural basis for the mechanistic understanding of human CD38-controlled multiple catalysis

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100487

7 January 2021

Catalysis-associated conformational changes revealed by human CD38 complexed with a non-hydrolyzable substrate analog

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100487

7 January 2021

Structural basis for formation and hydrolysis of the calcium messenger cyclic ADP-ribose by human CD38

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100487

7 January 2021

Covalent and Noncovalent Intermediates of an NAD Utilizing Enzyme, Human CD38

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100487

7 January 2021

Structural Basis for Enzymatic Evolution from a Dedicated ADP-ribosyl Cyclase to a Multifunctional NAD Hydrolase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100487

7 January 2021

Design, synthesis and biological characterization of novel inhibitors of CD38.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100487

7 January 2021

Large-scale production of human CD38 in yeast by fermentation

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100487

7 January 2021

Design and SAR of novel potassium channel openers targeted for urge urinary incontinence. 1. N-Cyanoguanidine bioisosteres possessing in vivo bladder selectivity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100487

7 January 2021

Synthesis and structure-activity relationships of 3,4-diaminocyclobut-3-ene-1,2-dione CXCR2 antagonists

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100487

7 January 2021

Discovery of 2-hydroxy-N,N-dimethyl-3-{2-[[(R)-1-(5- methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide (SCH 527123): a potent, orally bioavailable CXCR2/CXCR1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100487

7 January 2021

Synthesis and structure-activity relationships of heteroaryl substituted-3,4-diamino-3-cyclobut-3-ene-1,2-dione CXCR2/CXCR1 receptor antagonists

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100487

7 January 2021

Identifiers

DOI

10.1002/CMDC.201100487

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22287152%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference